An evidence-based review of prognostic factors for glaucomatous visual field progression

Ophthalmology

Volumn 120, Issue 3, 2013, Pages 512-519

  Ernest, Paul J ^a,b   Schouten, Jan S ^a   Beckers, Henny J ^a   Hendrikse, Fred ^a   Prins, Martin H ^b   Webers, Carroll A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CENTRAL CORNEAL THICKNESS; CONSENSUS; DECISION MAKING; DISEASE ASSOCIATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MYOPIA; OPEN ANGLE GLAUCOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOEXFOLIATION; RAYNAUD PHENOMENON; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

DISEASE PROGRESSION; EXFOLIATION SYNDROME; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; PROGNOSIS; RETINAL HEMORRHAGE; RISK FACTORS; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 84875219212     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.09.005     Document Type: Article

References (42)

1. Y.H. Kwon, J.H. Fingert, M.H. Kuehn, W.L. Alward Primary open-angle glaucoma N Engl J Med 360 2009 1113 1124
2. P.P. Chen Blindness in patients with treated open-angle glaucoma Ophthalmology 110 2003 726 733 (Pubitemid 36520071)
3. M.G. Hattenhauer, D.H. Johnson, H.H. Ing The probability of blindness from open-angle glaucoma Ophthalmology 105 1998 2099 2104 (Pubitemid 30211780)
4. A. Heijl, B. Bengtsson, L. Hyman, M.C. Leske Early Manifest Glaucoma Trial Group Natural history of open-angle glaucoma Ophthalmology 116 2009 2271 2276
5. D.E. Grobbee, A.W. Hoes Prognostic Research D.E. Grobbee, A.W. Hoes, Clinical Epidemiology: Principles, Methods, and Applications for Clinical Research 2009 Jones and Bartlett Publ. Sudbury, MA 104 106
6. A.L. Coleman, S. Miglior Risk factors for glaucoma onset and progression Surv Ophthalmol 53 Suppl 2008 S3 S10
7. M.V. Boland, H.A. Quigley Risk factors and open-angle glaucoma: classification and application J Glaucoma 16 2007 406 418 (Pubitemid 46945541)
8. M.A. Kass, A.E. Kolker, B. Becker Prognostic factors in glaucomatous visual field loss Arch Ophthalmol 94 1976 1274 1276 (Pubitemid 8265536)
9. P.J. Ernest, W. Viechtbauer, J.S. Schouten The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis Acta Ophthalmol 90 2012 10 19
10. P.J. Ernest, J.S. Schouten, H.J. Beckers The evidence base to select a method for assessing glaucomatous visual field progression Acta Ophthalmol 90 2012 101 108
11. L.P. Julvez, J.B. Del Castillo Sanchez, J.G. Feijoo, C. Rubio Terres Methodologic quality of studies on prognostic factors for primary open-angle glaucoma progression measured by visual field deterioration J Glaucoma 19 2010 587 591
12. Ophthalmology. Guide for authors http://www.elsevier.com/framework- products/promis-misc/ophtha-guideforauthors2012.pdf Accessed August 1, 2012
13. J.A. Hayden, P. Cote, C. Bombardier Evaluation of the quality of prognosis studies in systematic reviews Ann Intern Med 144 2006 427 437 (Pubitemid 46768164)
14. C. Wesselink, M.W. Marcus, N.M. Jansonius Risk factors for visual field progression in the Groningen Longitudinal Glaucoma Study: a comparison of different statistical approaches J Glaucoma 2011 Jun 22 [Epub ahead of print]
15. Deeks JJ, Higgins JP, Altman DG, Cochrane Statistical Methods Group, eds. Chapter 9.5.1: What is heterogeneity? J.P. Higgins, S. Green Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration www.cochrane-handbook.org Accessed August 28, 2012
16. C.M. Olthoff, J.S. Schouten, B.W. van de Borne, C.A. Webers Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review Ophthalmology 112 2005 953 961 (Pubitemid 40797446)
17. J. Cohen Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit Psychol Bull 70 1968 213 220
18. J.L. Fleiss, J. Cohen The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability Educ Psychol Meas 33 1973 613 619
19. M.R. Wilson Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies Trans Am Ophthalmol Soc 100 2002 365 410 (Pubitemid 37039380)
20. J.W. Kim, P.P. Chen Central corneal pachymetry and visual field progression in patients with open-angle glaucoma Ophthalmology 111 2004 2126 2132 (Pubitemid 39446734)
21. B. Schwartz, T. Takamoto, J. Martin Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma J Glaucoma 13 2004 120 129 (Pubitemid 38372822)
22. K. Nouri-Mahdavi, D. Hoffman, A.L. Coleman Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study Ophthalmology 111 2004 1627 1635 (Pubitemid 39179673)
23. L. Daugeliene, T. Yamamoto, Y. Kitazawa Risk factors for visual field damage progression in normal-tension glaucoma eyes Graefes Arch Clin Exp Ophthalmol 237 1999 105 108 (Pubitemid 29137296)
24. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 12 Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma Am J Ophthalmol 134 2002 499 512
25. J. Caprioli, A.L. Coleman Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study Ophthalmology 115 2008 1123 1129
26. T.S. Prata, C.G. De Moraes, C.C. Teng Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage Ophthalmology 117 2010 24 29
27. A. Martinez, M. Sanchez Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study Clin Ther 30 2008 1120 1134 (Pubitemid 351978120)
28. K.G. Ahrlich, C.G. De Moraes, C.C. Teng Visual field progression differences between normal-tension and exfoliative high-tension glaucoma Invest Ophthalmol Vis Sci 51 2010 1458 1463
29. C.G. De Moraes, T.S. Prata, C. Tello Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression Arch Ophthalmol 127 2009 1129 1134
30. C.C. Teng, C.G. De Moraes, T.S. Prata Beta-Zone parapapillary atrophy and the velocity of glaucoma progression Ophthalmology 117 2010 909 915
31. K. Ishida, T. Yamamoto, K. Sugiyama, Y. Kitazawa Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma Am J Ophthalmol 129 2000 707 714 (Pubitemid 30604147)
32. K. Ishida, T. Yamamoto, Y. Kitazawa Clinical factors associated with progression of normal-tension glaucoma J Glaucoma 7 1998 372 377 (Pubitemid 30247081)
33. A. Sawada, Y. Kitazawa, T. Yamamoto Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma Ophthalmology 103 1996 283 288 (Pubitemid 26066211)
34. B.C. Chauhan, F.S. Mikelberg, A.G. Balaszi Canadian Glaucoma Study Group Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma Arch Ophthalmol 126 2008 1030 1036
35. D.C. Musch, B.W. Gillespie, P.R. Lichter CIGTS Study Investigators Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors Ophthalmology 116 2009 200 207
36. M.B. Shields Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19 2008 85 88 (Pubitemid 351322808)
37. A. Sommer Ocular hypertension and normal-tension glaucoma: time for banishment and burial Arch Ophthalmol 129 2011 785 787
38. D.Y. Leung, C.C. Tham, F.C. Li Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study Ophthalmology 116 2009 1250 1256
39. D.Y. Leung, F.C. Li, Y.Y. Kwong Simvastatin and disease stabilization in normal tension glaucoma: a cohort study Ophthalmology 117 2010 471 476
40. M.A. Kass, B. Becker Genetics of primary open-angle glaucoma Sight Sav Rev 48 1978 21 28 (Pubitemid 8346378)
41. F.A. Medeiros, R.N. Weinreb Predictive models to estimate the risk of glaucoma development and progression Prog Brain Res 173 2008 15 24
42. M.V. Boland, H.A. Quigley, H.P. Lehmann The impact of risk calculation on treatment recommendations made by glaucoma specialists in cases of ocular hypertension J Glaucoma 17 2008 631 638